2-[(tert-Butoxycarbonyl)amino]-3,3,3-trifluoro-2-methylpropanoic acid, 95.0%, 1g

4,6-Dichloro-2-methyl-2h-pyrazolo[3,4-d]pyrimidine, 95+%, 1g

5-Amino-1,3,6-trimethyl-1,3-dihydro-benzoimidazol-2-one, 95.0%, 25g

2-Amino-5-chlorobenzotrifluoride, 97.0%, 500g

Methanone, (4-chlorophenyl)[4-(8-nitro-5-quinolinyl)-1-piperazinyl]-, 97%, 1g

(R)-3-(2-Bromophenyl)-3-((tert-butoxycarbonyl)amino)propanoic acid, 95.0%, 1g

4-Chloro-2-fluoro-5-methoxy benzaldehyde, 97.0%, 1g

Methyl 2,5-dibromonicotinate, 95.0%, 250mg

7-Aminobenzo[d]oxazol-2(3H)-one, 95.0%, 100mg

GC capillary column ROTI®Cap-1701, 15 m, 0.53 mm, 2.00 µm, 1 Piece(s)

(S)-1-([1,1'-biphenyl]-4-yl)-3-chloropropan-2-ol, 98%, 100mg

(E)-N-(4-((E)-3,5-Dimethoxystyryl)phenyl)-3-(3,4,5-trimethoxyphenyl)acrylamide, 98%, 25mg

5-Iodo-2-methylphenol, 98.0%, 5g